KRS Global Biotechnology, Inc. is recalling 223,330 units of various sterile injectable medications, including Alpha Lipoic Acid, Ascorbic Acid, Fentanyl Citrate, and Ketamine, due to a lack of assurance of sterility. Using products that are not properly sterilized can lead to life-threatening infections, particularly since these medications are administered through IV, injection, or in the eye. These prescription-only medications were distributed nationwide to healthcare facilities and clinics.
The lack of sterility assurance means the medications may be contaminated with microorganisms. If an unsterile product is injected into the body or eyes, it can cause severe systemic infections, inflammation, or other serious health complications.
Healthcare provider guidance and pharmacist refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.